Table 2.
Baseline characteristics of study cohorts
| Control | CoV-AKI-RRT | |||
| Parameter | All (n=51) | All (n=52) | ≥1 Shortened | No Shortened |
| SLED Run (n=44) | SLED Run (n=8) | |||
| Age (yr) | 63 (33–88) | 60 (39–81) | 58 (39–80) | 71 (62–81)a |
| Sex (%) | ||||
| Men | 34 (67) | 42 (79) | 35 (80) | 5 (62) |
| Women | 17 (33) | 11 (21) | 9 (20) | 3 (38) |
| Race (%) | ||||
| Black | 14 (27) | 37 (71)b | 33 (75) | 4 (50) |
| White | 34 (67) | 13 (25)b | 10 (23) | 3 (38) |
| Hispanic | 2 (4) | 2 (4) | 1 (2) | 1 (13) |
| Asian | 1 (2) | 0 | 0 | 0 |
| BMI (kg/m2) | 32 (20–53) | 38 (24–67)b | 39 (24–67) | 33 (29–40)c |
| DM | 17 (33%) | 27 (52%) | 24 (55%) | 3 (38%) |
| CKD | 20 (39%) | 18 (35%) | 14 (32%) | 4 (50%) |
| HTN | 32 (63%) | 42 (81%) | 37 (84%) | 4 (50%)c |
Data are presented as n (%), except for age and BMI [median (range)]. CoV-AKI-RRT, patients with coronavirus disease 2019 who developed AKI requiring RRT; SLED, sustained low efficiency dialysis; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension.
a
P<0.01 versus ≥1 shortened run group.
b
P<0.001 versus control.
c
P<0.05 versus ≥1 shortened run group.